Abstract Details

Title Evaluating Cognitive Benefits in Patients with Moderate-to-Severe Alzheimer's Disease Treated with Donepezil 23 mg/Day: Utility of the SIB-8 Scale

Topic Aging and Dementia

Presentation(s) (-)

Poster/Presentation
Number 221

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Frederick A. Schmitt, PhD (University of Kentucky)	The institution of Dr. Schmitt has received research support from NIH.
Joan Mackell (Pfizer Inc)	No disclosure on file
Sharon Richardson, MD (Pfizer)	No disclosure on file
	No disclosure on file
	No disclosure on file
Christian Foerch	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��